IDGGW (Interpace Biosciences) Common Stock : $0.41 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Interpace Biosciences Common Stock?

Interpace Biosciences's quarterly common stock stayed the same from Jun. 2024 ($0.41 Mil) to Sep. 2024 ($0.41 Mil) and stayed the same from Sep. 2024 ($0.41 Mil) to Dec. 2024 ($0.41 Mil).

Interpace Biosciences's annual common stock stayed the same from Dec. 2022 ($0.41 Mil) to Dec. 2023 ($0.41 Mil) but then increased from Dec. 2023 ($0.41 Mil) to Dec. 2024 ($0.41 Mil).

Interpace Biosciences Common Stock Historical Data

The historical data trend for Interpace Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpace Biosciences Common Stock Chart

Interpace Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.40

0.41

Interpace Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															0.41	0.41	0.41	0.41	0.41

Interpace Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Interpace Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Interpace Biosciences Inc (OTCPK:IDGGW) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

IDXG:USA

Address

2001 Route 46, Suite 310, Waterview Plaza, Parsippany, NJ, USA, 07054

Website

https://www.interpace.com

Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features. The company develops and commercializes genomic tests and related first-line assays that can personalize medicine and help improve patient diagnosis and management. Its clinical customers mainly consist of physicians, hospitals, cancer centers, commercial laboratories, pathology groups, and clinics. The various diagnostic tests offered by the company include ThyGeNEXT and ThyraMIRv2 for the detection of thyroid cancer, PancraGEN for pancreatic and biliary cancer, RespriDx for lung cancer, and BarreGEN for the detection of esophageal cancer.